MedTrace Logo

Resolution of Primary Immune Defect in 22q11.2 Deletion Syndrome

NCT02460328 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2016-03-23

No results posted yet for this study

Summary

* Evaluate about age of resolution in immune defect in 22q11.2 Deletion Syndrome
* Incidence of immunodeficiencies in 22q11.2 Deletion Syndrome

Conditions

  • Immune Defect
  • 22q11.2 Deletion Syndrome

Sponsors & Collaborators

  • Mahidol University

    lead OTHER

Principal Investigators

  • Punchama Pacharn, MD. · Mahidol University

Eligibility

Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • Thailand

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02460328 on ClinicalTrials.gov